Angiotech Pharmaceuticals Inc's ticker is and the CUSIP is 034918201. A total of 1 filers reported holding Angiotech Pharmaceuticals Inc in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $105,000 | +32.9% | 12,500 | 0.0% | 0.01% | +30.0% |
| Q1 2015 | $79,000 | 0.0% | 12,500 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $79,000 | -2.5% | 12,500 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $81,000 | -4.7% | 12,500 | 0.0% | 0.01% | +11.1% |
| Q2 2014 | $85,000 | -22.0% | 12,500 | 0.0% | 0.01% | -25.0% |
| Q1 2014 | $109,000 | -35.5% | 12,500 | 0.0% | 0.01% | -20.0% |
| Q4 2013 | $169,000 | +40.8% | 12,500 | 0.0% | 0.02% | +36.4% |
| Q3 2013 | $120,000 | -61.5% | 12,500 | 0.0% | 0.01% | -62.1% |
| Q2 2013 | $312,000 | – | 12,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCHNEIDER CAPITAL MANAGEMENT CORP | 12,500 | $79,000 | 0.01% |